azelaic acid
NDC 0591-2131, azelaic acid, gel, from Actavis Pharma, Inc..
- Product NDC
- 0591-2131
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208011
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZELAIC ACID.15 g/g
Pharmacologic classes
Decreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0591-2131-55 | 00591213155 | 1 TUBE in 1 CARTON (0591-2131-55) / 50 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/66298d50-d4e2-4852-bbab-581389c488cbNADAC price for package 00591213155
GET /v1/drugs/nadac/00591213155
Use it
Look up 0591-2131 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0591-2131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.